Skip to main content
Livermore
Livermore
ZHEN

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

SNDX holding history

Syndax Pharmaceuticals Inc in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SNDX overviewAll 13F holders of SNDXFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of SNDX by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−28,312−100.0%Sold outHolders
Q4 202528,312$594.8K<0.1%−93,155−76.7%ReducedHolders
Q3 2025121,467$1.87M<0.1%−366,180−75.1%ReducedHolders
Q2 2025487,647$4.57M<0.1%+21,765+4.7%AddedHolders
Q1 2025465,882$5.72M<0.1%+134,582+40.6%AddedHolders
Q4 2024331,300$4.38M<0.1%+283,577+594.2%AddedHolders
Q3 202447,723$918.7K<0.1%−22,458−32.0%ReducedHolders
Q2 202470,181$1.44M<0.1%−38,464−35.4%ReducedHolders
Q1 2024108,645$2.59M<0.1%−658−0.6%ReducedHolders
Q4 2023109,303$2.36M<0.1%+3,163+3.0%AddedHolders
Q3 2023106,140$1.54M<0.1%−488,322−82.1%ReducedHolders
Q2 2023594,462$12.4M<0.1%−725,763−55.0%ReducedHolders
Q1 20231,320,225$27.9M<0.1%+54,096+4.3%AddedHolders
Q4 20221,266,129$32.2M<0.1%+143,677+12.8%AddedHolders
Q3 20221,122,452$27.0M<0.1%+161,346+16.8%AddedHolders
Q2 2022961,106$18.5M<0.1%+76,772+8.7%AddedHolders
Q1 2022884,334$15.4M<0.1%+90,634+11.4%AddedHolders
Q4 2021793,700$17.4M<0.1%+145,674+22.5%AddedHolders
Q3 2021648,026$12.4M<0.1%+146,228+29.1%AddedHolders
Q2 2021501,798$8.62M<0.1%−207,841−29.3%ReducedHolders
Q1 2021709,639$15.8M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.